Wutah dodolan YoY sajrone rolas wulan kepungkur: MiMedx Corp (MDXG)

Logo grafis MiMedx Group, Inc. (MDXG)

MiMedx Group, Inc. (MDXG) dominates the tissue regeneration segment thanks to its unique bio-patches, although it faces pressure from synthetic alternatives and insurance risks. The sales dynamics over the last 12 months compared to the previous year help assess business resilience, where the current level equals -22.50. A positive trend is supported by the development of the EpiFix product line and the introduction of innovative allografts for healing complex wounds.

Wutah dodolan YoY sajrone rolas wulan kepungkur: MiMedx Group (MDXG) kanggo 11.02.2024 - 18.11.2026

Ringkesan rincian data analitis MiMedx Group Inc (MDXG)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:MDXG MiMedx Corp
Produk seri MiMedx

This indicator measures revenue dynamics over the last twelve months, filtering out short-term market fluctuations to identify the actual business scaling trend. Analyzing the last twelve months (LTM) revenue growth rate allows for stress-testing the portfolio for asset overpayment, confirming that the growth of MiMedx Group, Inc. (MDXG) is driven not by random spikes, but by the effective commercialization of products supported by a strong R&D core.

Pesaing MiMedx Group, Inc. (MDXG)

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur MBX|Wutah dodolan YoY sajrone rolas wulan kepungkur Altimmune Pharma (ALT)|Wutah dodolan YoY sajrone rolas wulan kepungkur AARD (Aardvark Therapeutics Corp)|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)